StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.85+0.19 (+11.45%)

Close on Nov 17, 2026Market cap $32.54MP/E –Yield –

Cel Sci revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2014 it was $264.03K, up 65.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2014Sep 30, 2014$264.03K+65.5%
FY2013Sep 30, 2013$159.58K-37.3%
FY2012Sep 30, 2012$254.61K-73.4%
FY2011Sep 30, 2011$956.15K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2017CQ2 2017Jun 30, 2017$17.39K–

More Cel Sci figures

See a number that looks wrong?